Technological advances are helping shape the dosage forms of the future.

The Shape of Dosage Forms

CDMOs offer expertise and capacity for spray drying.

Spray Drying Finds Growing Use for ASDs

Workforce training is crucial for biopharmaceutical manufacturing.

Single-Use System Training 

Topic

Articles

Moderna has filed for emergency use authorization of its COVID-19 vaccine for use in young children six months to under six years of age.

Moderna Submits EUA of COVID-19 Vaccine for Use in Young Children

GeoVax has received a patent for its malaria vaccine from the US Patent and Trademark Office.

USPTO Issues Malaria Vaccine Patent to GeoVax

EMA has granted Novo Nordisk a positive scientific opinion on human insulin with more flexible storage without refrigeration.

Novo Nordisk Announces Positive Scientific Opinion from EMA on Human Insulin

The European Investment Bank has provided €15 million to fund coronavirus research at IRBM.

EIB Provides €15 million to IRBM

Podcasts

In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, interviews Joy Aho, senior product manager at Be The Match BioTherapies, about sourcing autologous and allogeneic cell therapies.

Drug Solutions Podcast: Sourcing Autologous and Allogeneic Cell Therapies

ReiThera and Exothera are collaborating to develop a large-scale, low-cost-per-dose manufacturing process to deliver novel vaccines to low and middle-income countries.

ReiThera and Exothera Collaborate on Manufacturing Vaccines for Low and Middle-income Countries

Dupixent has been approved by the EC for children aged 6 to 11 years with severe asthma with type 2 inflammation.

EC Approves Dupixent for Treatment of Severe Asthma in Young Children

FDA has granted Priority Review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalized adults.

FDA Grants Priority Review to Intravenous Treatment of COVID-19 in Hospitalized Adults

ECDC and EMA have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines in the general population.

ECDC and EMA Issue Advice on Fourth Doses of mRNA COVID-19 Vaccines

NIH has announced four new grant awards to fund new tuberculosis research advancement centers. 